Here, we use comprehensive bioinformatics analyses and experimental validations to investigate SLC7A11's role in the liver cancer immune microenvironment, elucidate the underlying regulatory mechanisms, and offer insights on the RFA combination therapy model for HCC. Here, SLC7A11 is linked to liver cancer.